NgospelMedia.Net
NgospelMedia.net is The No. 1 International Urban Gospel Media Website, The Largest Repository of Your Favorite Gospel Entertainment Website, Worldwide, Nigeria. We Published Latest Nigerian and Foreign Gospel Music Downloads, Videos; Lyrics, Artiste Biography, Daily Devotionals. NgospelMedia is mainly a Christian Website, as the Domain Name Speaks; Gospel; Which is also tagged as a Gospel On-line Ministry for Souls Winning... 

- related posts -

Indonesian clerics declare Sinovac’s COVID-19 vaccine halal

5

- Advertisement -









Indonesian clerics declare Sinovac’s COVID-19 vaccine halal 1

JAKARTA – A COVID-19 vaccine produced by Sinovac Biotech is deemed halal, or permissible under Islam, the Indonesian Ulema Council said on Friday, days before the country is scheduled to start its inoculation program using the Chinese vaccine.

Indonesia, the world’s largest Muslim-majority country, has 3 million doses of CoronaVac and plans to use it when it starts its vaccination programme on Wednesday, with President Joko Widodo due to receive the first shot.

Asrorun Niam Sholeh of the council’s fatwa commission told a news conference that Sinovac’s CoronaVac was “holy and halal”, although authorisation for its use still rests on Indonesia’s food and drug agency (BPOM).

“This could be the information that could soothe the people, especially Muslims,” Niam said.

Indonesia is struggling with the worst COVID-19 epidemic in Southeast Asia and authorities are relying on a vaccine to help alleviate the health and economic crises ravaging the country.

It confirmed a record daily rise in COVID-19 cases for the third consecutive day on Friday, reporting more than 10,000 daily infections for the first time and passing the 800,000 mark in cases, among the highest number in Asia.

It reported 10,617 new infections on Friday, taking total cases to 808,340. It has recorded 23,753 deaths.

Regulator BPOM has said it is hopeful that emergency use approval for CoronaVac, which depends on the results of the vaccine’s Indonesian trials, will be issued before Wednesday.

CoronaVac was 78 percent effective in a late-stage Brazilian trial with no severe COVID-19 cases, researchers said on Thursday.

- Advertisement -

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

- Advertisement -

- related posts -

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More